- Home
- AARD vs PINE Comparison
AARD vs PINE Comparison
Compare AARD & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | PINE |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.9M | 232.7M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AARD | PINE |
|---|---|---|
| Price | $13.38 | $17.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $30.63 | $17.67 |
| AVG Volume (30 Days) | ★ 178.7K | 151.7K |
| Earning Date | 11-13-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $57,423,000.00 |
| Revenue This Year | N/A | $14.13 |
| Revenue Next Year | N/A | $2.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.81 |
| 52 Week Low | $4.88 | $13.10 |
| 52 Week High | $19.58 | $17.99 |
Technical Indicators
Market Signals| Indicator | AARD | PINE |
|---|---|---|
| Relative Strength Index (RSI) | 66.65 | 75.69 |
| Support Level | $9.18 | $17.00 |
| Resistance Level | $10.44 | $17.54 |
| Average True Range (ATR) | 0.91 | 0.43 |
| MACD | 0.46 | -0.00 |
| Stochastic Oscillator | 94.75 | 95.85 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.